Catalyst Wire Dossier Catalyst Wire Dossier

Leflunomide medac

leflunomide · medac Gesellschaft für klinische Spezialpräparate mbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Leflunomide medac, covering 2025-12-19 to 2026-08-04. Get the full timeline:

Most recent: EMA Authorised: Leflunomide medac (leflunomide) — medac Gesellschaft für klinische Spezialpräparate mbH

See pricing